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ABSTRACT
Objective: To evaluate retinoblastoma, according to histological grades, TNM staging and age at presentation.
Materials and Methods:  This cross sectional study was conducted in Department of Pathology BMSI- JPMC Karachi from
1st January 2009 to 31st December 2013 during which a total of 80 cases of retinoblastoma were received. Out of which 68 were
reviewed and morphological diagnosis was done on H&E staining. Histological grades and TNM staging were categorized.
The data was analyzed by using SPSS version 22.
Results: In 80 cases of retinoblastoma the mean age of patients was 3.64 years with 3-4 years (53.75%) of age being the
commonest. Amongst 68 cases, well differentiated retinoblastoma were seen in 7.35%, moderately differentiated 11.76%, poorly
differentiated 26.47% and undifferentiated 51.41% cases. Varied pattern of TNM staging were observed. Majority (60.29%)
in stage IV followed by 19.11% in stage I and 10.29% each in TNM stage II and III. Regional lymph node metastasis was seen
in 4/68 cases (5.88%) while 3/68 (4.41%) showed distant (CNS) metastasis. All these cases (7/7) were in TNM stage IV with
majority showing grade 4 (75%) and grade 3 (25%) histology.
Conclusion: Evaluation of retinoblastoma showed that commonest age group was 3-4 years. Majority of retinoblastoma cases
were undifferentiated (G4) followed by poorly differentiated (G3). While in TNM staging  system varied pattern was observed,
majority were in stage IV followed by Stage I. Majority of lymph node and distant metastasis  were seen in grade 4 histology
and all of  them were in TNM stage IV.
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INTRODUCTION:
The commonest primary intraocular cancer in younger
age is retinoblastoma1,2,3 generally affects children, early
diagnosis is curable while untreated cases lead to
complications and even death4. Retinoblastoma arises
as mutation in both alleles of Rb1 gene which occurs
pre-zygotically or post-zygotically in germ cells5. Rb1
gene is situated in long arm of chromosome 13q14 4,6,7,8
Hereditary form consists of 30-40% and non hereditary
form 60-70%. Former had bilateral retinoblastoma,
diagnosed in < 1 year of age and have more risk of
secondary neoplasm that is bone and soft tissue sarcoma,
melanoma and brain cancer. Latter have unilateral
retinoblastoma, diagnosed at 2-5 years of age and is not
prone to secondary neoplasm. 9,10,11,12
Globally one case of retinoblastoma is recorded in up
to 20,000 live births. Incidence is generally equal in
North America, Europe, Australia and Asia whereas
higher in Africa and other developing countries.13,14,15,16,17
When retinoblastoma spread to the optic nerve, choroid
and extra ocular tissue the mortality is high and prognosis
is poor18,19,20,21 Grossly retinoblastoma are presented as
endophytic, exophytic, mixed endophytic  and exophytic,
diffuse infiltrating and complete spontaneous
regression.3,7,8,22
On the basis of Flexner-Winter Steiner rosette (Lined
by tall cuboidal cells that circumscribed an apical lumen
and basal ends of the cells contain nuclei), Homer-
Wright rossettes (cells are not arranged about a lumen
but sends out cytoplasmic processes and form a tangle
within the center) and pseudo rosette, retinoblastoma
are divided into well differentiated, moderately
differentiated, poorly differentiated and undifferentiated
variant.7,9,22,,23,24 On involvement of optic nerve, choroid,
extraocular tissue and secondary metastasis to lymph
node and distant tissue, TNM staging system of
retinoblastoma developed, T is primary tumor, N is
lymph node and M is distant metastasis.7,22,23,24,25
This study was designed to evaluate retinoblastoma
cases according to different histological grades, TNM
staging and age at presentation in our local population.
MATERIALS AND METHODS:
The study was performed after approval from BASR,
Karachi University at department of Pathology Basic
Medical Sciences Institute, Jinnah Postgraduate Medical
Center (BMSI-JPMC) Karachi from 1st January 2009
to 31st December 2013.  A total of 80 cases of retinoblas-
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toma were received and 12 cases were excluded due to
inadequate material. In remaining 68 cases histological
grading and TNM staging was done. These patients
were operated at ophthalmology department of JPMC,
Karachi. All enucleated eye specimens were included,
while poorly fixed and inadequate tissue, ocular tumor
other than retinoblastoma and metastatic tumors were
excluded. Formalin fixed, paraffin embedded blocks,
surgical pathology, clinical records and hematoxyline
and eosin slides were used. Sections were taken and
stained with H&E. all slides were studied under light
microscope using scanner (4X), low power (10X)
followed by high power (40X). The data was analyzed
by using statistical package for social sciences (SPSS)
version 22.
RESULTS:
Distribution of retinoblastoma according to age amongst
80 cases was, majority that is 53.75% cases were between
ages 3-4 years followed by 20% cases in 5-6 years. The
mean ± SD were 3.64 years (43.68 months) ±1.74,
median age was 48 months. The minimum age was 02
months while maximum age noted was 09 years (Table 1)
Table: 1
Distribution of retinoblastoma according to age
(n=80)
Out of 68 cases, 7.35% were well differentiated (G1),
11.76% were moderately differentiated (G2), 26.47%
were poorly differentiated (G3) and 54.41% were
undifferentiated (G4) respectively. Out of 68 cases
5.88% cases showed regional lymph node and 4.41%
showed distant metastasis, majority i.e. 75% of them
were in G4 histology and 25% showed G3 histology
(Table 2).
Table: 2
Distribution of retinoblastoma according to
 histological grades
 (n=68)
Distribution of retinoblastoma according to TNM staging
system showed that out of 68 cases majority that is
60.29% were in TNM stage IV followed by 19.11%
were stage I and 10.29% each were in TNM stage II
and stage III. All the cases that showed regional lymph
node and CNS metastasis, were in TNM stage IV (Table 3)
Table: 3
Cases of retinoblastoma according to TNM staging
(n=68)
CI: Confidence interval
Comparison and correlation of retinoblastoma according
to TNM staging and histological grading showed that
out of 68 cases majority that is 60.29% were in TNM
stage IV. Out of these 2.43% were in histological grade
I, 7.13% in G2, 29.26% in G3 and 60.29% in G4. TNM
stage III showed 10.29% out of these 0% were in grade
I, 14.28% in G2, 28.57% in G3 and 57.14% in G4. TNM
stage II showed 10.29% out of these 28.57% each were
in grade I, grade 2 and grade 4 histology While 14.28%
in G3. TNM stage I showed 19.11% out of these 15.38%
each were in histological grade 1 and grade 2, 23.07%
in G3 and 46.15% in G4 (Table 4).
Table: 4
Retinoblastoma according to histopathological grading
and TNM staging
(n= 68)
P value = 0.22; Chi Square = 11.77
DISCUSSION
In present study the most common age group was 3-4
years that is 53.75% cases followed by 20% cases in 5-
6 years age group. These findings are comparable to the
studies in Mumbai, India, Tata Memorial Hospital by
Yeole13 and Akhiwu6 have reported 76.5% and 78%
cases in under 4 years of age and 3-3.5 years of age
groups respectively. Studies by Chintagumpala1 and
Rodrigues 20 have reported 80% cases under 3 years and
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   Age           No of  Percentage Cumulative
(years)           cases        %      index
<1 year             04        05        05
1-2 years            11     13.75     18.75
3-4 years            43     53.75      72.5
5-6 years            16       20      92.5
7-8 years            02     02.50       95
9-10 years          01     01.25     96.25
Unknown           03     03.75      100
Total             80      100
Grades         No of          Percentage               95% CI
         cases      %
G1           05       07.35  2.74-15.54
G2           08                11.76  5.61-21.11
G3           18        26.47   17.0-37.9
G4           37                54.41 42.51-65.94
Total           68      100
Stage No of % of total    95% CI
cases    cases
Stage I 13                      19.11 11.06-29.75
Stage II 07    10.29   4.61-19.3
Stage III 07    10.29   4.61-19.3
Stage IV 41    60.29  48.34-71.4
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53% cases under 2 years of age respectively. In this
study the mean age was 43.68 months. This finding was
comparable with the work by Akhiwu 6 who has reported
 mean age 24 to 48 months, but dissimilar to Antoneli
21 and Arif 2 who have documented  28.7 and 32 months
respectively. Dissimilarity with present study may be
due to lack of awareness, lack of education and poverty
leading to late presentation for medical consultation.
In the present study varied histopathological grades
were seen. Majority that is 54.41% were in grade 4
histology followed by 26.47% in G3, 11.76% in G2 and
7.35% in grade 1 histology. A Nigerian study conducted
by Owoeys9 have reported 82% and 17.4% cases in G3
and G1 and none of case in grade 1 and grade 4 histology.
While Chinese study performed by Jia19 has reported
24%, 14% and 62% cases in histopathological grade 1,
G2 and G3 respectively. No case was reported in
histological grade 4 while present study found majority
of cases in grade 4 histology. This variation could be
due to late presentation or genetic and environmental
factors.
Similarly an interesting observation in this series was
that TNM staging had variable pattern of presentation
and majority were in stage IV followed by stage I and
equal number of cases were in TNM stage II and stage
III. The reason for patient being in high TNM stage at
the time of clinical presentation as mentioned earlier
may be due to lack of awareness and inaccessibility of
proper medical services. Moreover, people prefer
alternative medical therapy such as Hakeems before
consulting doctors.
CONCLUSION:
Maximum number of retinoblastoma cases was seen in
the age group of 3-4 years and majority of them had
grade-4 histology. Most of these cases were seen in
Stage IV. All cases of lymph node and distant metastasis
were also seen in TNM stage IV.
In view of a high stage and grade at the time of
presentation wide scale awareness through education to
parents, community and counseling programs is needed.
This will help to ensure early presentation of such cases
that is in the initial stages and grades of the disease.
This in turn could improve the clinical outcomes,
morbidity and mortality in such cases.
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